top of page
Search

GLP-1 Agonists in Perimenopause: Unique Risks and Potential Opportunities

  • PMS
  • Oct 16
  • 1 min read

Recent data suggests that use of GLP-1s is highest for perimenopausal women in the United States. Despite widespread use of these drugs by perimenopausal women, research has largely ignored the unique risks and potential opportunities for optimizing health that GLP-1s may pose in this population. Full article here.

ree

.

 
 
 

Comments

​

​

Follow us on Instagram

 

© 2025 by The Perimenopause Society. Powered and secured by Wix 

 

Make a donation

Your donation is tax deductible and supports The Perimenopause Society’s operations and is entered into a pool for funding novel research on perimenopause diagnostics and treatment.  Thank you!

Amount

$
bottom of page